Creso delivers second consecutive quarter of record revenue growth
Finfeed
Archived
Jul 01, 2021
Creso Pharma (ASX: CPH) has achieved strong sales growth for the June quarter generating a total of A$1,715,933 - a 24% increase on the previous quarter (Q1 CY2021: A$1,385,000).
